133 related articles for article (PubMed ID: 31305530)
1. NMR-Based Activity Assays for Determining Compound Inhibition, IC50 Values, Artifactual Activity, and Whole-Cell Activity of Nucleoside Ribohydrolases.
Stockman BJ; Kaur A; Persaud JK; Mahmood M; Thuilot SF; Emilcar MB; Canestrari M; Gonzalez JA; Auletta S; Sapojnikov V; Caravan W; Muellers SN
J Vis Exp; 2019 Jun; (148):. PubMed ID: 31305530
[TBL] [Abstract][Full Text] [Related]
2. Adenosine/guanosine preferring nucleoside ribohydrolase is a distinct, druggable antitrichomonal target.
Beck S; Muellers SN; Benzie AL; Parkin DW; Stockman BJ
Bioorg Med Chem Lett; 2015 Nov; 25(22):5036-9. PubMed ID: 26592812
[TBL] [Abstract][Full Text] [Related]
3. Ligand-Efficient Inhibitors of Trichomonas vaginalis Adenosine/Guanosine Preferring Nucleoside Ribohydrolase.
Muellers SN; Gonzalez JA; Kaur A; Sapojnikov V; Benzie AL; Brown DG; Parkin DW; Stockman BJ
ACS Infect Dis; 2019 Mar; 5(3):345-352. PubMed ID: 30701958
[TBL] [Abstract][Full Text] [Related]
4. Direct Measurement of Nucleoside Ribohydrolase Enzyme Activities in
Stockman BJ; Ventura CA; Deykina VS; Khayan Lontscharitsch N; Saljanin E; Gil A; Canestrari M; Mahmood M
Anal Chem; 2023 Mar; 95(12):5300-5306. PubMed ID: 36917470
[TBL] [Abstract][Full Text] [Related]
5. Iminoribitol transition state analogue inhibitors of protozoan nucleoside hydrolases.
Miles RW; Tyler PC; Evans GB; Furneaux RH; Parkin DW; Schramm VL
Biochemistry; 1999 Oct; 38(40):13147-54. PubMed ID: 10529186
[TBL] [Abstract][Full Text] [Related]
6. Identification of proton-pump inhibitor drugs that inhibit Trichomonas vaginalis uridine nucleoside ribohydrolase.
Shea TA; Burburan PJ; Matubia VN; Ramcharan SS; Rosario I; Parkin DW; Stockman BJ
Bioorg Med Chem Lett; 2014 Feb; 24(4):1080-4. PubMed ID: 24468412
[TBL] [Abstract][Full Text] [Related]
7. The use of biochemical and biophysical tools for triage of high-throughput screening hits - A case study with Escherichia coli phosphopantetheine adenylyltransferase.
Miller JR; Thanabal V; Melnick MM; Lall M; Donovan C; Sarver RW; Lee DY; Ohren J; Emerson D
Chem Biol Drug Des; 2010 May; 75(5):444-54. PubMed ID: 20486930
[TBL] [Abstract][Full Text] [Related]
8. Discovery of Ligand-Efficient Scaffolds for the Design of Novel
Auletta S; Caravan W; Persaud JK; Thuilot SF; Brown DG; Parkin DW; Stockman BJ
ACS Omega; 2019 Oct; 4(14):16226-16232. PubMed ID: 31592163
[TBL] [Abstract][Full Text] [Related]
9. Druggability of the guanosine/adenosine/cytidine nucleoside hydrolase from Trichomonas vaginalis.
Alam R; Barbarovich AT; Caravan W; Ismail M; Barskaya A; Parkin DW; Stockman BJ
Chem Biol Drug Des; 2018 Oct; 92(4):1736-1742. PubMed ID: 29808562
[TBL] [Abstract][Full Text] [Related]
10. Targeting the Plasmodium vivax equilibrative nucleoside transporter 1 (PvENT1) for antimalarial drug development.
Deniskin R; Frame IJ; Sosa Y; Akabas MH
Int J Parasitol Drugs Drug Resist; 2016 Apr; 6(1):1-11. PubMed ID: 26862473
[TBL] [Abstract][Full Text] [Related]
11. An NMR-Based Chemometric Strategy to Identify
Casanova LM; Rodrigues LM; de Aguiar PF; Tinoco LW
J Nat Prod; 2020 Feb; 83(2):243-254. PubMed ID: 31985226
[TBL] [Abstract][Full Text] [Related]
12. Isozyme-specific transition state inhibitors for the trypanosomal nucleoside hydrolases.
Parkin DW; Limberg G; Tyler PC; Furneaux RH; Chen XY; Schramm VL
Biochemistry; 1997 Mar; 36(12):3528-34. PubMed ID: 9132003
[TBL] [Abstract][Full Text] [Related]
13. [NMR screening of potential inhibitors of Citrobacter freundii methionine].
Batuev EA; Lizunov AIu; Morozova EA; Klochkov VV; Anufrieva NV; Demidkina TV; Pol'shakov VI
Mol Biol (Mosk); 2014; 48(6):1019-29. PubMed ID: 25845243
[TBL] [Abstract][Full Text] [Related]
14. Kinetics and docking studies of two potential new inhibitors of the nucleoside hydrolase from Leishmania donovani.
Rennó MN; França TC; Nico D; Palatnik-de-Sousa CB; Tinoco LW; Figueroa-Villar JD
Eur J Med Chem; 2012 Oct; 56():301-7. PubMed ID: 22947894
[TBL] [Abstract][Full Text] [Related]
15. Target-based whole-cell screening by ¹H NMR spectroscopy.
Ma J; Cao Q; McLeod SM; Ferguson K; Gao N; Breeze AL; Hu J
Angew Chem Int Ed Engl; 2015 Apr; 54(16):4764-7. PubMed ID: 25693499
[TBL] [Abstract][Full Text] [Related]
16. Identification of B. anthracis N(5)-carboxyaminoimidazole ribonucleotide mutase (PurE) active site binding compounds via fragment library screening.
Lei H; Jones C; Zhu T; Patel K; Wolf NM; Fung LW; Lee H; Johnson ME
Bioorg Med Chem; 2016 Feb; 24(4):596-605. PubMed ID: 26740153
[TBL] [Abstract][Full Text] [Related]
17. Applications of Biophysics in High-Throughput Screening Hit Validation.
Genick CC; Barlier D; Monna D; Brunner R; Bé C; Scheufler C; Ottl J
J Biomol Screen; 2014 Jun; 19(5):707-14. PubMed ID: 24695619
[TBL] [Abstract][Full Text] [Related]
18. A High-Throughput Enzyme-Coupled Assay for SAMHD1 dNTPase.
Seamon KJ; Stivers JT
J Biomol Screen; 2015 Jul; 20(6):801-9. PubMed ID: 25755265
[TBL] [Abstract][Full Text] [Related]
19. Assay interference and off-target liabilities of reported histone acetyltransferase inhibitors.
Dahlin JL; Nelson KM; Strasser JM; Barsyte-Lovejoy D; Szewczyk MM; Organ S; Cuellar M; Singh G; Shrimp JH; Nguyen N; Meier JL; Arrowsmith CH; Brown PJ; Baell JB; Walters MA
Nat Commun; 2017 Nov; 8(1):1527. PubMed ID: 29142305
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
